Wider statin use recommended for chronic kidney disease

Wider statin use recommended for chronic kidney disease

(HealthDay)—New guidelines for lipid management in chronic kidney disease (CKD) recommend wider statin use, according to a clinical practice guideline published online Dec. 10 in the Annals of Internal Medicine.

Marcello Tonelli, M.D., from the University of Alberta in Edmonton, Canada, and colleagues reviewed and graded the evidence and developed a on lipid management and treatment of all adults and children with CKD.

The guidelines include 13 recommendations, with eight recommendations relating to assessment of lipid status and treatment with statin-based regimens. For adults ≥50 years with an estimated (eGFR) <60 mL/min/1.73 m², not treated with chronic dialysis or kidney transplantation, treatment with a statin or statin/ezetimibe combination is recommended. Statin treatment is recommended for adults aged ≥50 years with CKD and eGFR ≥60 mL/min/1.73 m². Younger adults (18 to 49 years) with CKD who are not treated with chronic dialysis or kidney transplantation should receive statin treatment if they have at least one of the following: known coronary disease, diabetes mellitus, prior ischemic stroke, or >10 percent estimated 10-year incidence of coronary death or non-fatal myocardial infarction. Statins or statin/ezetimibe combinations should not be initiated for adults with dialysis-dependent CKD, although treatment can be continued for those receiving it at dialysis initiation. Adult should also be treated with a statin. Adults with newly identified CKD should be evaluated with a lipid profile, but follow-up measurements are not required.

"Within the guideline, implications for clinical practice, future research, and implementation in international settings are highlighted," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

More information: Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New hope for rare disease drug development

1 hour ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

4 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

5 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

Anti-diabetic drug springs new hope for tuberculosis patients

12 hours ago

A more effective treatment for tuberculosis (TB) could soon be available as scientists have discovered that Metformin (MET), a drug for treating diabetes, can also be used to boost the efficacy of TB medication without inducing ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.